MedTrace Logo

Effects of Spirulina Supplementation on Overweight or Obese Adults

NCT02993627 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2019-04-11

No results posted yet for this study

Summary

In this double-blind Randomized Controlled Clinical Trial investigators are going to study the effects of Spirulina supplementation on anthropometric measurements, lipid profile, appetite, liver enzymes, inflammatory and glycemic markers in a sample of overweight or obese adults.

Conditions

Interventions

DIETARY_SUPPLEMENT

Spirulina

2 g(4\* 500 mg tablets) daily intake of Spirulina Platensis

OTHER

diet therapy

low calorie diet (-500 or -300 kcal) composed of 55% carbohydrate, 15% protein and 30% fat

Sponsors & Collaborators

  • Shahid Beheshti University of Medical Sciences

    lead OTHER

Principal Investigators

  • Atoosa Saidpour · Shahid Beheshti University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-07-31
Completion
2017-12-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02993627 on ClinicalTrials.gov